ADALAT

This brand name is authorized in Austria, Brazil, Canada, Estonia, Spain, Hong Kong, Ireland, Italy, Japan, Mexico, Nigeria, Netherlands, New Zealand, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug ADALAT contains one active pharmaceutical ingredient (API):

1 Nifedipine UNII I9ZF7L6G2L - NIFEDIPINE

Nifedipine is a calcium antagonist of the 1,4-dihydropyridine type. Calcium antagonists reduce the transmembranal influx of calcium ions through the slow calcium channel into the cell. As a specific and potent calcium antagonist, nifedipine acts particularly on the cells of the myocardium and the smooth muscle cells of the coronary arteries and the peripheral resistance vessels. The main action of nifedipine is to relax arterial smooth muscle, both in the coronary and peripheral circulation. Nifedipine Tablets are formulated to achieve controlled delivery of nifedipine in a release profile sufficient to enable once-daily administration to be effective in clinical use. Read about Nifedipine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ADALAT Tablet	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C08CA05	Nifedipine	C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 538912060016913, 538912060017113, 538912060017203, 538912060017303, 538912060017513, 538912060017613, 538912060017713
Country: CA	Health Products and Food Branch	Identifier(s): 02155907
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00047757, 02739175, 02739181, 03344415, 03344421, 03352076, 03352082
Country: EE	Ravimiamet	Identifier(s): 1006311, 1042456, 1042467, 1072606, 1072617, 1072640, 1154517, 1784112, 1809705
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 56920, 59538
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 28816
Country: HK	Department of Health Drug Office	Identifier(s): 37008
Country: IE	Health Products Regulatory Authority	Identifier(s): 10773, 56031, 56335, 56336, 56337, 56393, 56395
Country: IT	Agenzia del Farmaco	Identifier(s): 027980010, 027980022, 039782026, 043514013, 043514025, 043515016, 044052013
Country: JP	医薬品医療機器総合機構	Identifier(s): 2171014G3022, 2171014G4029, 2171014G5025
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 86126
Country: NG	Registered Drug Product Database	Identifier(s): A4-2374
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 33693, 33707
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2888, 2889, 2890
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63872001, W63872002
Country: SG	Health Sciences Authority	Identifier(s): 07710P, 08913P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699546031870, 8699546032501
Country: ZA	Health Products Regulatory Authority	Identifier(s): 27/7.1/0294, A39/7.1/0634, S/7.1/393, Y/7.1/314, Y/7.1/315